Literature DB >> 19164486

UDP-glucose modulates gastric function through P2Y14 receptor-dependent and -independent mechanisms.

Anna K Bassil1, Sophie Bourdu, Karen A Townson, Alan Wheeldon, Emma M Jarvie, Noureddine Zebda, Alejandro Abuin, Evelyn Grau, George P Livi, Lorraine Punter, Judith Latcham, Angela M Grimes, David P Hurp, Kelly M Downham, Gareth J Sanger, Wendy J Winchester, Alastair D Morrison, Gary B T Moore.   

Abstract

P2Y receptors have been reported to modulate gastrointestinal functions. The newest family member is the nucleotide-sugar receptor P2Y14. P2ry14 mRNA was detected throughout the rat gut, with the highest level being in the forestomach. We investigated the role of the receptor in stomach motility using cognate agonists and knockout (KO) mice. In rat isolated forestomach, 100 microM UDP-glucose and 100 muM UDP-galactose both increased the baseline muscle tension (BMT) by 6.2+/-0.6 and 1.6+/-0.6 mN (P<0.05, n=3-4), respectively, and the amplitude of contractions during electrical field stimulation (EFS) by 3.7+/-1.7 and 4.3+/-2.5 mN (P<0.05, n=3-4), respectively. In forestomach from wild-type (WT) mice, 100 microM UDP-glucose increased the BMT by 1.0+/-0.1 mN (P<0.05, n=6) but this effect was lost in the KO mice (change of -0.1+/-0.1 mN, n=6). The 100 microM UDP-glucose also increased the contraction amplitude during EFS in this tissue from the WT animals (0.9+/-0.4 mN, P < 0.05, n=6) but not from the KO mice (0.0+/-0.2 mN, n=6). In vivo, UDP-glucose at 2,000 mg/kg ip reduced gastric emptying in rats by 49.7% (P<0.05, n=4-6) and in WT and KO mice by 56.1 and 66.2%, respectively (P<0.05, n=7-10) vs. saline-treated control animals. There was no significant difference in gastric emptying between WT and KO animals receiving either saline or d-glucose. These results demonstrate a novel function of the P2Y14 receptor associated with contractility in the rodent stomach that does not lead to altered gastric emptying after receptor deletion and an ability of UDP-glucose to delay gastric emptying without involving the P2Y14 receptor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19164486     DOI: 10.1152/ajpgi.90363.2008

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  17 in total

1.  The impact of commercially available purinergic ligands on purinergic signalling research.

Authors:  J R Flanaghan; S J Roome
Journal:  Purinergic Signal       Date:  2011-10-27       Impact factor: 3.765

Review 2.  Signalling and pharmacological properties of the P2Y receptor.

Authors:  T K Harden; J I Sesma; I P Fricks; E R Lazarowski
Journal:  Acta Physiol (Oxf)       Date:  2010-03-24       Impact factor: 6.311

3.  GPR105 ablation prevents inflammation and improves insulin sensitivity in mice with diet-induced obesity.

Authors:  Jianfeng Xu; Hidetaka Morinaga; Dayoung Oh; Pingping Li; Ai Chen; Saswata Talukdar; Yaël Mamane; Joseph A Mancini; Andrea R Nawrocki; Eduardo Lazarowski; Jerrold M Olefsky; Jane J Kim
Journal:  J Immunol       Date:  2012-07-09       Impact factor: 5.422

4.  P2Y14 Receptor Antagonists Reverse Chronic Neuropathic Pain in a Mouse Model.

Authors:  Fatma Mufti; Young-Hwan Jung; Luigino Antonio Giancotti; Jinha Yu; Zhoumou Chen; Ngan B Phung; Kenneth A Jacobson; Daniela Salvemini
Journal:  ACS Med Chem Lett       Date:  2020-04-30       Impact factor: 4.345

Review 5.  P2Y receptors in the mammalian nervous system: pharmacology, ligands and therapeutic potential.

Authors:  Gary A Weisman; Lucas T Woods; Laurie Erb; Cheikh I Seye
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-09       Impact factor: 4.388

6.  Genome-wide profiling of in vivo LPS-responsive genes in splenic myeloid cells.

Authors:  Myeong Sup Lee; Byungil Kim; Sun-Min Lee; Woo-Cheul Cho; Wook-Bin Lee; Ji-Seon Kang; Un Yung Choi; Jaemyun Lyu; Young-Joon Kim
Journal:  Mol Cells       Date:  2013-05-10       Impact factor: 5.034

Review 7.  UDP-Sugars as Extracellular Signaling Molecules: Cellular and Physiologic Consequences of P2Y14 Receptor Activation.

Authors:  Eduardo R Lazarowski; T Kendall Harden
Journal:  Mol Pharmacol       Date:  2015-03-31       Impact factor: 4.436

8.  Purinergic P2Y₁₄ receptor modulates stress-induced hematopoietic stem/progenitor cell senescence.

Authors:  Joonseok Cho; Rushdia Yusuf; Sungho Kook; Eyal Attar; Dongjun Lee; Baehang Park; Tao Cheng; David T Scadden; Byeong Chel Lee
Journal:  J Clin Invest       Date:  2014-06-17       Impact factor: 14.808

9.  The G protein-coupled receptor P2Y14 influences insulin release and smooth muscle function in mice.

Authors:  Jaroslawna Meister; Diana Le Duc; Albert Ricken; Ralph Burkhardt; Joachim Thiery; Helga Pfannkuche; Tobias Polte; Johannes Grosse; Torsten Schöneberg; Angela Schulz
Journal:  J Biol Chem       Date:  2014-07-03       Impact factor: 5.157

10.  Enhanced potency of nucleotide-dendrimer conjugates as agonists of the P2Y14 receptor: multivalent effect in G protein-coupled receptor recognition.

Authors:  Arijit Das; Yixing Zhou; Andrei A Ivanov; Rhonda L Carter; T Kendall Harden; Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2009-07-02       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.